BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//The BioCalendar - ECPv6.16.3//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:The BioCalendar
X-ORIGINAL-URL:https://thebiocalendar.com
X-WR-CALDESC:Events for The BioCalendar
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Los_Angeles
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20250309T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20251102T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20260308T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20261101T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20270314T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20271107T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20260308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20261101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20270314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20271107T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260427
DTEND;VALUE=DATE:20260501
DTSTAMP:20260530T202935
CREATED:20260327T142423Z
LAST-MODIFIED:20260327T142423Z
UID:10109-1777248000-1777593599@thebiocalendar.com
SUMMARY:BPI Europe
DESCRIPTION:Join us as we return to Vienna\, a globally recognized meeting destination and one of Europe’s premier life science hubs. The city is home to the renowned Vienna BioCenter\, a nexus of academic research and over 50 innovative biotech companies\, alongside industry leaders like Boehringer Ingelheim\, Takeda and Novartis. This powerful combination of scientific excellence\, seamless accessibility\, and rich cultural heritage provides the ideal backdrop to connect with global pioneers and forge the collaborations that will drive the future of bioprocessing.
URL:https://thebiocalendar.com/event/bpi-europe/
LOCATION:Vienna\, Vienna\, 1300\, Austria
CATEGORIES:Seminar
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260428
DTEND;VALUE=DATE:20260430
DTSTAMP:20260530T202935
CREATED:20251209T120633Z
LAST-MODIFIED:20251209T120633Z
UID:9639-1777334400-1777507199@thebiocalendar.com
SUMMARY:Cell & Gene Therapy Summit
DESCRIPTION:A Decade of Expertise\, Now in China: Cell & Gene Therapy Summit 2026 \n\n\n\nWith over a decade of experience hosting premier cell and gene therapy events in the US and Europe\, attracting 1\,500+ attendees annually\, Cell & Gene Therapy International is bringing its expertise to China. The 2026 summit in Shanghai is designed to foster collaboration among top researchers\, biopharmaceutical leaders\, and industry pioneers\, with a focus on cutting-edge R&D\, manufacturing excellence\, and strategic partnerships. Attendees will gain unparalleled insights into breakthrough methodologies across cell therapies\, gene editing platforms\, viral vector technologies\, and the discovery-to-clinic continuum—empowering them to drive innovation and growth in the China market.
URL:https://thebiocalendar.com/event/cell-gene-therapy-summit/
LOCATION:Shanghai\, Shanghai\, China
CATEGORIES:Summit
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260428
DTEND;VALUE=DATE:20260430
DTSTAMP:20260530T202935
CREATED:20251210T120316Z
LAST-MODIFIED:20251210T120316Z
UID:9640-1777334400-1777507199@thebiocalendar.com
SUMMARY:ChinaBio Partnering Forum
DESCRIPTION:The ChinaBio Partnering Forum is China’s premier life science event\, connecting global biopharma with China’s market for strategic partnerships\, investment\, and innovation\, featuring partneringONE technology\, company pitches (like Startup Spotlight)\, expert panels\, and networking to accelerate cross-border deals.
URL:https://thebiocalendar.com/event/chinabio-partnering-forum-3/
LOCATION:Shanghai\, Shanghai\, China
CATEGORIES:Forum,Partnering
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260428
DTEND;VALUE=DATE:20260501
DTSTAMP:20260530T202935
CREATED:20260130T130200Z
LAST-MODIFIED:20260202T184211Z
UID:9838-1777334400-1777593599@thebiocalendar.com
SUMMARY:3rd Biophysics for Drug Discovery Summit 
DESCRIPTION:The 3rd Biophysics for Drug Discovery Summit offers a rare\, highly technical\, industry-focused forum dedicated solely to biophysics. Unlike broader drug discovery meetings\, this summit provides a comprehensive view of techniques\, emerging technologies\, and practical applications. Through case studies\, panel discussions\, and interactive dialogue\, attendees will explore how next-generation biophysics drives predictive pipelines and accelerates discovery.  \nTo find out more\, please view the full 2026 event program here: https://ter.li/efenue
URL:https://thebiocalendar.com/event/3rd-biophysics-for-drug-discovery-summit/
LOCATION:Boston\, MA\, 02210\, United States
CATEGORIES:Summit
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260429T110000
DTEND;TZID=America/Los_Angeles:20260429T120000
DTSTAMP:20260530T202935
CREATED:20260327T123222Z
LAST-MODIFIED:20260327T123222Z
UID:10100-1777460400-1777464000@thebiocalendar.com
SUMMARY:Driving Smarter Chemistry in Drug Discovery: Using Full DEL Data to Improve Early Compound Decisions
DESCRIPTION:Modern screening approaches generate rich datasets that capture how large collections of compounds interact with biological targets. However\, discovery teams often rely on only a small portion of that information when selecting compounds for synthesis\, potentially missing important signals across the broader dataset. \nIn this webinar\, we explore how evaluating the full screening landscape can reveal structure–function insight across related compounds. This approach helps guide more informed chemistry decisions. By looking beyond individual hits\, scientists can better understand which chemical series merit further investment and which should be deprioritized earlier in the program. \nKey Learning Objectives:\n– How evaluating the full DEL screening dataset can reveal meaningful patterns across related compounds\, not just individual enriched binders\n– Why examining structure–function trends across chemical series can improve confidence in early synthesis decisions\n– How a more complete view of DEL data can help discovery teams prioritize the right series and reduce downstream risk
URL:https://thebiocalendar.com/event/driving-smarter-chemistry-in-drug-discovery-using-full-del-data-to-improve-early-compound-decisions/
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/03/04-29-26-XChem-eBlast-700x200-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260429T110000
DTEND;TZID=America/Los_Angeles:20260429T120000
DTSTAMP:20260530T202935
CREATED:20260407T114850Z
LAST-MODIFIED:20260407T114850Z
UID:10134-1777460400-1777464000@thebiocalendar.com
SUMMARY:Execution Without Direction: The Hidden Risk in Outsourced Clinical Trials
DESCRIPTION:As clinical trials become increasingly outsourced\, a critical gap has emerged between sponsor expectations and CRO execution. Many smaller biotech companies rely heavily on outsourcing vendors to drive their programs\, often without the internal clinical operations infrastructure needed to provide direction\, oversight\, and strategic alignment. \nAt the same time\, vendor teams—particularly CRAs—are frequently stretched thin and charged with executing small tasks without understanding the bigger picture. The result is a growing disconnect: between sponsors and CROs\, CRAs and sites\, and protocols and real-world operations. These gaps can lead to inefficiencies\, risks\, and strained site relationships that ultimately impact study success. \nIn this live webinar\, industry experts will explore the root causes of this disconnect and examine whether clinical oversight monitors are a necessary evolution\, or an added layer of complexity. Through real-world insights and practical examples\, we’ll discuss how organizations can better align stakeholders\, improve trial execution\, and close the widening operational gap. \nIn this webinar\, you will:\n– Understand the structural gaps that commonly exist between sponsors\, CROs\, and clinical sites\n– Learn why traditional CRO models may fall short in providing strategic clinical oversight\n– Identify the risks and inefficiencies that arise from fragmented clinical operations\n– Explore the role of oversight functions in improving alignment\, quality\, and site relationships\n– Gain practical strategies for strengthening collaboration and ensuring more cohesive trial execution
URL:https://thebiocalendar.com/event/execution-without-direction-the-hidden-risk-in-outsourced-clinical-trials/
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/04/04-29-26-ISG-eBlast-700x200-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260429T130000
DTEND;TZID=America/Los_Angeles:20260429T140000
DTSTAMP:20260530T202935
CREATED:20260323T180943Z
LAST-MODIFIED:20260323T180943Z
UID:10055-1777467600-1777471200@thebiocalendar.com
SUMMARY:How Connected Manufacturing Operations Unlock AI's Potential to Optimize Production
DESCRIPTION:Research findings from 150 manufacturing leaders uncovered a “connectivity crisis” preventing production optimization. This webinar addresses the imperative to break down the silos today that are creating the delays\, rework\, and compliance issues that 90%-plus manufacturers struggle with. Start at the bottom and build the connected data foundation that makes AI actually work.
URL:https://thebiocalendar.com/event/how-connected-manufacturing-operations-unlock-ais-potential-to-optimize-production/
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/03/04-29-26-MasterControl-Reg-1920x250-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260430T110000
DTEND;TZID=America/Los_Angeles:20260430T120000
DTSTAMP:20260530T202935
CREATED:20260323T183444Z
LAST-MODIFIED:20260323T183444Z
UID:10059-1777546800-1777550400@thebiocalendar.com
SUMMARY:Alert to Action: How Connected Digital Execution Turns Pharma Data into Decisions
DESCRIPTION:In this session\, explore how digitally connected execution ecosystems move manufacturers from reactive response to proactive control\, enabling faster decisions\, fewer errors\, and inspection-ready operations by design.
URL:https://thebiocalendar.com/event/alert-to-action-how-connected-digital-execution-turns-pharma-data-into-decisions/
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/03/04-30-26-Honeywell-Reg-1920x250-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260430T110000
DTEND;TZID=America/Los_Angeles:20260430T120000
DTSTAMP:20260530T202935
CREATED:20260330T113959Z
LAST-MODIFIED:20260330T113959Z
UID:10111-1777546800-1777550400@thebiocalendar.com
SUMMARY:Radiopharmaceuticals: New Opportunities And Overcoming Operational Hurdles
DESCRIPTION:Radiopharmaceuticals and radioligand therapies were involved in multibillion dollar M&A transactions over the last several years. Panelists on this Life Science Leader virtual event will discuss emerging technologies and radioisotopes\, what new market opportunities exist\, and what manufacturing and delivery challenges remain for radiopharmaceutical developers.   \nRegistered attendees will have the opportunity to pose their own questions to panel participants\, so come prepared to connect\, collaborate\, and contribute on April 30\, 2026\, 11 AM ET.
URL:https://thebiocalendar.com/event/radiopharmaceuticals-new-opportunities-and-overcoming-operational-hurdles/
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/03/26_04-LSL-LinkedIn-1280x720-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260430T110000
DTEND;TZID=America/Los_Angeles:20260430T120000
DTSTAMP:20260530T202935
CREATED:20260407T190132Z
LAST-MODIFIED:20260407T190132Z
UID:10150-1777546800-1777550400@thebiocalendar.com
SUMMARY:Engineering Precision in Genetic Medicines
DESCRIPTION:Discover how precision genome editing is advancing the next generation of genetic medicines. Learn strategies to achieve highly specific\, potent DNA edits while minimizing off-target effects and meeting rigorous safety standards for clinical translation. \nWhat you’ll learn:\n– How to precisely correct disease mutations without creating unwanted edits\n– Engineering and optimizing DNA recognition to enhance specificity across genome editing modalities\n– AI-driven iterative workflows for designing bespoke gene editors with both high potency and specificity\n– Practical strategies to minimize bystander and off-target editing for safer therapeutics\n– Real-world insights from using adenine base editors as a case study
URL:https://thebiocalendar.com/event/engineering-precision-in-genetic-medicines/
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/04/04-30-26-Elevate-eBlast-700x200-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260430T160000
DTEND;TZID=America/Los_Angeles:20260430T190000
DTSTAMP:20260530T202935
CREATED:20260327T132452Z
LAST-MODIFIED:20260327T132452Z
UID:10104-1777564800-1777575600@thebiocalendar.com
SUMMARY:Life Sciences PA Tailgate250
DESCRIPTION:Kickoff the America250 celebrations with the fifth annual Life Sciences PA Tailgate! \nJoin us April 30\, 2026 in the heart of Philadelphia and at life sciences hub\, The Lawn @uCity Square\, for food trucks\, games\, live music\, and networking with other life sciences professionals. \nRegister as an individual to enjoy the fun of the tailgate atmosphere without any setup\, or purchase a 10×10 space on the square and bring your team to decorate with tents\, chairs\, games and more to showcase your organization. \nWHEN: THURSDAY\, APRIL 30\, 2026 \nNEW LOCATION: The Lawn @ uCity Square – 3701 Filbert Street\, Philadelphia\, PA 19104 \nNEW TIME: 4:00 pm – 7:00 pm \nWHAT IS INCLUDED IN YOUR REGISTRATION: \n• 🎵 Live Music from local member company bands \n• 🚚 Food Trucks offering both sweet and savory options \n• 🍻 Beer Garden hosted onsite \n• 🤝 Networking with hundreds of life sciences professionals \n• 🎉 Games\, giveaways\, and community fun \nWHO ATTENDS \n• Biotech\, pharma\, medtech\, diagnostics\, and digital health professionals \n• Emerging and early stage companies \n• Leading service providers \n• Academic and research institutions \n• Regional innovation partners
URL:https://thebiocalendar.com/event/life-sciences-pa-tailgate250/
LOCATION:Philadelphia\, Philadelphia\, PA\, United States
CATEGORIES:Social
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260430T163000
DTEND;TZID=America/Los_Angeles:20260430T183000
DTSTAMP:20260530T202935
CREATED:20260326T150945Z
LAST-MODIFIED:20260326T151200Z
UID:10084-1777566600-1777573800@thebiocalendar.com
SUMMARY:BVS and Ventura BioCenter's Life Science Community Event in Thousand Oaks
DESCRIPTION:We are very excited to announce our outdoor Ventura BioCenter Life Science Community Event in Thousand Oaks! \nMark your calendars for a great opportunity to connect with industry leaders\, explore innovative products\, and mingle with fellow professionals in the biotech community. \n✨ What to Expect: \nVendor Exhibits: Discover a diverse range of exhibitors showcasing cutting-edge technology and services in the biotech space. \nNetworking Opportunities: Engage with fellow industry experts\, forge new connections\, and exchange ideas that could shape the future of biotech. \nDelicious BBQ & Drinks: Enjoy a delicious BBQ\, beer & wine as you network and explore the vendor exhibits. \nJoin your colleagues from Amgen\, ADRx\, AGQ Labs\, Arcutis Biotherapeutics\, Atara Biotherapeutics\, Cal State Channel Islands\, Capsida Biotherapeutics\, Curia Global\, Hygiena\, LungLife AI\, PBS Biotech\, Takeda\, and all of the companies in the Ventura BioCenter\, along with many suppliers for a great event and get together. \nAdmission Details:\nFREE for life science job-related employees (including researchers\, scientists\, purchasing\, clinical\, manufacturing\, non-sales/bus dev positions etc.) from life science companies and research institutes.\n$50 fee for product and service providers who sell to the life science community (e.g. BVS suppliers\, business development/sales\, marketing\, lawyers\, consultants)\, which includes access to the event but does not include an exhibitor table. Exhibitor tables can be purchased separately.\nFor exhibitor tables\, please visit our website and register at: https://bvsconnection.com/events \nPlease feel free to invite others in the community that could benefit from attending. \nWe look forward to seeing you there!
URL:https://thebiocalendar.com/event/outdoor-ventura-biocenter-life-science-community-event-in-thousand-oaks-2/
ATTACH;FMTTYPE=image/jpeg:https://thebiocalendar.com/wp-content/uploads/2026/03/VBC-Vendor-Show-Flyer-4-30-26.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260504
DTEND;VALUE=DATE:20260506
DTSTAMP:20260530T202935
CREATED:20251206T101622Z
LAST-MODIFIED:20260125T043207Z
UID:9626-1777852800-1778025599@thebiocalendar.com
SUMMARY:TRI-CON 2026
DESCRIPTION:Join us for an exclusive gathering of senior-level investors\, pharma executives\, entrepreneurs\, research thought leaders\, and innovators at the 33rd Annual TRI-CON. Connect with investors and partners at intimate networking sessions; gain strategic insights on funding activities\, business development\, and innovation strategies in diagnostics\, precision medicine\, and AI from industry-led panels; and hear candid perspectives and business recommendations from key opinion leaders during dynamic fireside chats. Building on a 30+ track record\, TRI-CON is positioned as the premier meeting place for key stakeholders to foster meaningful connections\, acquire valuable strategic insights\, and drive innovation and collaboration. Returning to San Francisco in 2026!
URL:https://thebiocalendar.com/event/tri-con-2026/
LOCATION:San Francisco\, CA\, San Francisco\, CA\, United States
CATEGORIES:Featured,Investor,Networking,Partnering,Presentation,Summit
ATTACH;FMTTYPE=image/jpeg:https://thebiocalendar.com/wp-content/uploads/2026/01/tric-scaled.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260504
DTEND;VALUE=DATE:20260508
DTSTAMP:20260530T202935
CREATED:20260327T140336Z
LAST-MODIFIED:20260327T140336Z
UID:10105-1777852800-1778198399@thebiocalendar.com
SUMMARY:SynBioBeta 2026
DESCRIPTION:Join our SynBioBeta community for three days of high-signal talks\, curated 1:1 meetings\, real partnering\, and hands-on exposure at the frontier of biology and technology. \nGo deep on AI-driven biology and therapeutics. You’ll also get up to speed on sustainable biomanufacturing of chemicals\, materials\, food\, and consumer products\, and discover applications of biology that you never thought possible. \nThis is where global builders\, backers\, and scouts have mind-blowing conversations and find their next moves.
URL:https://thebiocalendar.com/event/synbiobeta-2026/
LOCATION:San Jose\, San Jose\, CA\, United States
CATEGORIES:Summit
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260504T110000
DTEND;TZID=America/Los_Angeles:20260504T120000
DTSTAMP:20260530T202935
CREATED:20260326T132035Z
LAST-MODIFIED:20260326T132035Z
UID:10076-1777892400-1777896000@thebiocalendar.com
SUMMARY:The Shift to High Concentration mAbs: 3 Critical UF/DF Challenges and How to Solve Them
DESCRIPTION:A practical look at overcoming viscosity\, fouling\, and aggregation with modern TFF platforms. \nAs monoclonal antibody therapies continue to evolve\, the industry is rapidly shifting from traditional mAb formulations to high‑concentration mAbs to enable subcutaneous delivery\, improve patient convenience\, and support next‑generation therapeutics. While this shift delivers clear clinical benefits\, it also introduces new risks and complexities particularly during ultrafiltration and diafiltration (UF/DF). \nIn this webinar\, we’ll examine how increasing protein concentration fundamentally changes UF/DF behavior—and why legacy approaches often struggle as viscosity rises and operating windows narrow. We’ll break down the three most critical UF/DF challenges associated with high‑concentration mAbs and discuss practical strategies to address them using modern TFF platforms. \nKey topics include:\n –   Why the industry is shifting toward high‑concentration mAbs—and what this means for downstream bioprocessing\n –   The three critical UF/DF challenges at high concentration:\n     ~     Managing viscosity and its impact on flux\, pressure\, and process control\n     ~     Preventing fouling and polarization that limit performance and scalability\n     ~     Reducing aggregation risk during concentration and diafiltration\n –   How modern\, automated TFF system design can help mitigate these risks\n –   What to consider when adapting UF/DF strategies for development\, scale‑up\, and manufacturing \nWhether you are developing next‑generation mAbs or scaling existing programs to higher concentrations\, this session will provide practical insights to help you build more robust\, repeatable UF/DF processes for the high‑concentration era.
URL:https://thebiocalendar.com/event/the-shift-to-high-concentration-mabs-3-critical-uf-df-challenges-and-how-to-solve-them/
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/03/05-04-26-Repligen-Linkedin-1280x720-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260504T130000
DTEND;TZID=America/Los_Angeles:20260504T140000
DTSTAMP:20260530T202935
CREATED:20260408T190440Z
LAST-MODIFIED:20260408T190440Z
UID:10172-1777899600-1777903200@thebiocalendar.com
SUMMARY:A Novel Cell Selective Lentiviral Platform for in vivo CAR-T Engineering
DESCRIPTION:Selective gene delivery to defined cell populations using targeted lentiviral vectors (LVV) represents a promising strategy for next‑generation immunotherapies such as chimeric antigen receptor (CAR) T‑cell therapy. While conventional CAR-T cell manufacturing requires multiple ex vivo manipulation steps up to two weeks\, targeted LVVs can enable a short ex vivo manufacturing process or direct in vivo generation of functional CAR-T cells with substantial lower complexity and cost\, improving accessibility to the therapy. \nWe have developed a novel paramyxovirus (PV)‑pseudotyped LVV platform designed for efficient gene transfer into non‑activated T cells ex vivo and in vivo. In this system\, viral binding and fusion are mediated by modified hemagglutinin (H) and fusion (F) glycoproteins respectively. Mutation of H abolishes natural tropism\, while retargeting is achieved by fusing cell‑specific single‑chain variable fragments (scFvs) or heavy‑chain variable domains (VHHs)\, enabling targeted transduction. \nUsing our high titer packaging cell line and an optimized transfection process\, we produced  CD4‑\, CD8‑\, and pan‑T‑cell–specific LVV\, which efficiently generated CAR-T cells in vitro and in vivo in a PBMC-transplanted NSG mouse model. Importantly\, these CAR-T cells led to robust tumor lysis in vitro and rapid tumor B-cell depletion in vivo\, highlighting the clinical feasibility of this approach.  \nIn summary\, our optimized targeted LVV platform enables selective and rapid generation of defined CAR-T cell subsets\, providing a foundation for safe\, cost-effective and accessible CAR-T cell therapies.
URL:https://thebiocalendar.com/event/a-novel-cell-selective-lentiviral-platform-for-in-vivo-car-t-engineering/
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/04/05-04-26-Miltenyi-LinkedIn-1280x720-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260505T110000
DTEND;TZID=America/Los_Angeles:20260505T120000
DTSTAMP:20260530T202935
CREATED:20260407T115320Z
LAST-MODIFIED:20260407T115320Z
UID:10138-1777978800-1777982400@thebiocalendar.com
SUMMARY:Organs-on-Chips: Tech Progress & Regulatory Tailwinds
DESCRIPTION:Microphysiological (MPS) systems are proving to be increasingly valuable for early drug discovery. By recreating human‑specific physiology—fluid flow\, barrier function\, multicellular interactions\, and organ‑level mechanics—organ‑on‑chip models generate insight that’s difficult to obtain from traditional cell lines or animals. They support target validation research and they enable early efficacy modeling for processes like neuroinflammation\, fibrosis\, barrier breakdown\, infection\, and metabolic dysfunction. Liver\, kidney\, lung\, gut\, cervix\, and BBB chips can also provide early tox\, PK/PD\, and ADME readouts; measuring metabolism\, clearance\, permeability\, and drug–drug interactions. Beyond these core areas\, chips offer windows into disease modeling\, including patient‑specific biology using iPSC‑derived cells\, and help de‑risk newer modalities that need human‑relevant microenvironments to behave predictably. Together\, these capabilities make MPS one of the most important emerging tools for building human biology into discovery from the start\, not just for avoiding late‑stage toxicology failures. \nThe panel will discuss the progress being made in these key areas and provide insight into the future of organ-on-chip model research. Register for free today.
URL:https://thebiocalendar.com/event/organs-on-chips-tech-progress-regulatory-tailwinds/
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/04/26_05_DDO_HTML_600x300.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260506T090000
DTEND;TZID=America/Los_Angeles:20260506T100000
DTSTAMP:20260530T202935
CREATED:20260408T172304Z
LAST-MODIFIED:20260408T172304Z
UID:10158-1778058000-1778061600@thebiocalendar.com
SUMMARY:Outsourcing Must Haves in 2026: Regional Supply Chain Strategy & Capacity – Top Experts and CDMO CEOs on Actionable Strategies
DESCRIPTION:Explore why regional supply chain diversification and strong CDMO partnerships are no longer optional\, but essential for resilience\, speed\, and compliance in 2026. Hear directly from top industry experts and CDMO leaders as they share actionable strategies\, real-world insights\, and urgent steps companies must take to secure capacity\, reduce risk\, and stay competitive.
URL:https://thebiocalendar.com/event/outsourcing-must-haves-in-2026-regional-supply-chain-strategy-capacity-top-experts-and-cdmo-ceos-on-actionable-strategies/
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/04/Biocal-14.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260506T110000
DTEND;TZID=America/Los_Angeles:20260506T170000
DTSTAMP:20260530T202935
CREATED:20260407T130644Z
LAST-MODIFIED:20260407T130645Z
UID:10142-1778065200-1778086800@thebiocalendar.com
SUMMARY:Reliable and comprehensive control in bioprocessing: Substrate\, metabolite and product analysis at one device
DESCRIPTION:In bio-process control\, including mammalian cell cultures as well as microbial fermentation\, Cedex Analyzers from Roche CustomBiotech enable fast and reliable determination of the relevant media components\, for optimization of the protocols and for monitoring of routine processes to achieve optimal yield and product quality. \nMore than 30 parameters can be analyzed on the same device\, including common culture control parameters like glucose\, glutamine\, lactate\, ammonia\, osmolality\, as well as typical products like monoclonal antibodies and modified variants thereof\, and also many special parameters required to be controlled in various applications\, (e.g. Ala-Gln\, Asn\, iron\, phosphate\, acetate\, glycerol\, methanol\, optical density\, …). \nFurthermore\, there are options provided for integration of the Cedex Analyzers in automated workflows\, for example with numerous small-scale bioreactors in the process development\, or with bio-manufacturing in high-scale fermenters in pharmaceutical or industrial biotech environments. \nKey learning objectives:\n    Learn about improving product yield and quality in culture-based bio-manufacturing\n    Get an overview of the available Cedex Analyzers test menu including latest extensions\n    See examples of Cedex Analyzer applications in pharmaceutical and industrial bio-processing
URL:https://thebiocalendar.com/event/reliable-and-comprehensive-control-in-bioprocessing-substrate-metabolite-and-product-analysis-at-one-device/
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/04/05-06-26-Roche-LinkedIn-1280x720-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260507
DTEND;VALUE=DATE:20260509
DTSTAMP:20260530T202935
CREATED:20260327T140922Z
LAST-MODIFIED:20260327T140922Z
UID:10108-1778112000-1778284799@thebiocalendar.com
SUMMARY:The Convergence Forum
DESCRIPTION:What opportunities get created as fields converge? What challenges surface as markets\, policies\, and investing dynamics shift? What new scientific discoveries are potential game-changers? Convergence exists to explore those questions (and many others)\, with a high-level audience interested in what’s happening in the rapidly-converging worlds of biotech\, pharma\, healthcare\, medical devices\, and the Internet. \nThe Convergence Forum fosters real debate and discussion among audiences that are every bit as high-level as the speakers. The programs provide an opportunity for participants to make important new contacts\, do business\, explore important new directions in research\, delve deeply into what it takes to maintain competitive advantage in a fast-changing world\, and leave feeling recharged.
URL:https://thebiocalendar.com/event/the-convergence-forum-2/
LOCATION:Cape Cod\, Harwich\, MA\, 02645\, United States
CATEGORIES:Forum
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260507T100000
DTEND;TZID=America/Los_Angeles:20260507T120000
DTSTAMP:20260530T202935
CREATED:20260327T122537Z
LAST-MODIFIED:20260327T122537Z
UID:10092-1778148000-1778155200@thebiocalendar.com
SUMMARY:Smart Sourcing: IRT/RTSM Technology Showcase
DESCRIPTION:Join us for a virtual expo built for clinical teams that need to evaluate Interactive Response Technology / Randomization & Trial Supply Management platforms.  \nSelecting the right supplier is a vital decision that impacts patient safety\, data integrity\, and site compliance.  \nThe Clinical Leader Solutions Expo is designed to support clinical research experts in accelerating their decision-making process. \nWhat to expect:\n✔ Live 15-minute product based presentations from leading IRT/RTSM vendors\n✔ Side-by-side comparisons. See real-world capabilities.\n✔ Real-time Q&A with each presenter.\n✔ Get the insights that matter to your team
URL:https://thebiocalendar.com/event/smart-sourcing-irt-rtsm-technology-showcase/
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/03/05-07-2026-CLSE-700x200-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260507T110000
DTEND;TZID=America/Los_Angeles:20260507T120000
DTSTAMP:20260530T202935
CREATED:20260408T172649Z
LAST-MODIFIED:20260408T172653Z
UID:10162-1778151600-1778155200@thebiocalendar.com
SUMMARY:Early Developability Assessment for Antibody Based Therapeutics
DESCRIPTION:Discover how integrated in silico and in vitro approaches can assess developability\, manufacturability\, and immunosafety at the earliest stages. Learn how a toolbox strategy enables smarter candidate selection\, reduces downstream risk\, and supports faster progression of multi-specific antibodies into clinical development. \nKey takeaways include:\n– Early identification of developability and immunosafety risks in multi-specific antibodies\n– How combined in silico and in vitro screening improves lead selection\n– Strategies to enhance manufacturability and product quality from the start\n– Using a toolbox approach to streamline development and accelerate timelines
URL:https://thebiocalendar.com/event/early-developability-assessment-for-antibody-based-therapeutics/
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/04/05-07-26-Lonza-eBlast-700x200-2.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260507T130000
DTEND;TZID=America/Los_Angeles:20260507T140000
DTSTAMP:20260530T202935
CREATED:20260402T160919Z
LAST-MODIFIED:20260402T160920Z
UID:10129-1778158800-1778162400@thebiocalendar.com
SUMMARY:How to Activate Industrial AI Under GxP\, Governance\, and Security Constraints
DESCRIPTION:This webinar invites an interactive dialogue to explore how Industrial AI can be introduced where plants are today. We’ll walk through what is real and working now to turn insights into governed\, auditable actions\, with human oversight by design.
URL:https://thebiocalendar.com/event/how-to-activate-industrial-ai-under-gxp-governance-and-security-constraints/
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/04/05-07-26-Siemens-Reg-Banner-1920x250-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260507T163000
DTEND;TZID=America/New_York:20260507T190000
DTSTAMP:20260530T202935
CREATED:20260415T164149Z
LAST-MODIFIED:20260415T164149Z
UID:10206-1778171400-1778180400@thebiocalendar.com
SUMMARY:JLL & BVS’ Spring Community Celebration in Tarrytown\, New York
DESCRIPTION:BVS in collaboration with JJL is excited to host our first indoor JLL & BVS’ Spring Community Celebration in Tarrytown. \nMark your calendars for a great opportunity to connect with industry leaders\, explore innovative products\, and mingle with fellow professionals in the biotech community. \nWe invite all entrepreneurs\, researchers\, and scientists from institutes\, biotech firms\, and other companies in Tarrytown and the surrounding areas to join us for this event. This gathering brings together professionals from the healthcare\, biotech\, academic\, and local business communities for networking\, collaboration\, and knowledge sharing. \n✨ What to Expect: \n    Vendor Exhibits: Discover a diverse range of exhibitors showcasing cutting-edge technology and services in the biotech space.\n    Networking Opportunities: Engage with fellow industry experts\, forge new connections\, and exchange ideas that could shape the future of biotech.\n    Lab Tours: Take a tour of the lab space available at 500 White Plains Road\n    Delicious Appetizers & Drinks: Enjoy delicious spring-inspired appetizers\, craft beer\, wine and the “Westchester Spring Spritz” Prosecco cocktail\, as you network and explore the vendor exhibits. \nAdmission Details: \n    FREE for life science job-related employees (including researchers\, scientists\, purchasing\, clinical\, manufacturing\, non-sales/bus dev positions etc.) from life science companies and research institutes.\n    $200 fee for product and service providers who sell to the life science community (e.g. BVS suppliers\, business development/sales\, marketing\, lawyers\, consultants)\, which includes access to the event but does not include an exhibitor table. Exhibitor tables can be purchased separately. \nFor exhibitor tables\, please visit our website and register at: https://bvsconnection.com/events \nPlease feel free to invite others in the community that could benefit from attending. \nWe look forward to seeing you there!
URL:https://thebiocalendar.com/event/jll-bvs-spring-community-celebration-in-tarrytown-new-york-2/
ATTACH;FMTTYPE=image/jpeg:https://thebiocalendar.com/wp-content/uploads/2026/04/BVS-Biotech-Event-Flyer-05-7-26-1.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260508
DTEND;VALUE=DATE:20260510
DTSTAMP:20260530T202935
CREATED:20260507T184645Z
LAST-MODIFIED:20260507T184645Z
UID:10402-1778198400-1778371199@thebiocalendar.com
SUMMARY:2026 @Philly Cell and Gene Therapy Annual Conference
DESCRIPTION:This meeting brings together the innovators and business leaders to foster collaborations and advance CGT in the Greater Philadelphia area.
URL:https://thebiocalendar.com/event/2026-philly-cell-and-gene-therapy-annual-conference/
LOCATION:King of Prussia\, PA\, King of Prussia\, PA\, 19406\, United States
CATEGORIES:Presentation,Summit
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260508T110000
DTEND;TZID=America/Los_Angeles:20260508T120000
DTSTAMP:20260530T202935
CREATED:20260408T173023Z
LAST-MODIFIED:20260408T173023Z
UID:10168-1778238000-1778241600@thebiocalendar.com
SUMMARY:From Insights to Impact: Predictive Models and PAT for More Efficient and Robust Biologics Manufacturing
DESCRIPTION:Explore how data-driven tools and Process Analytical Technology (PAT) can optimize scale-up\, enhance process control\, and reduce risk from cell culture through drug product. Learn how integrating advanced modeling and real-time monitoring enables more reliable\, cost-effective\, and scalable biologics production. \nKey takeaways include:\n– Applying predictive\, engineering-driven models to improve bioreactor scale-up and performance\n– Using mechanistic models and data to enable robust tech transfer and process optimization\n– Leveraging PAT tools for real-time monitoring\, adaptive control\, and process stability\n– Scaling lyophilization with design space approaches to ensure product quality and consistency\n– Reducing scale-up uncertainty and accelerating path to commercial manufacturing
URL:https://thebiocalendar.com/event/from-insights-to-impact-predictive-models-and-pat-for-more-efficient-and-robust-biologics-manufacturing/
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/04/05-08-26-Lonza-eBlast-700x200-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260511
DTEND;VALUE=DATE:20260516
DTSTAMP:20260530T202935
CREATED:20251206T101044Z
LAST-MODIFIED:20251206T101044Z
UID:9623-1778457600-1778889599@thebiocalendar.com
SUMMARY:ASGCT Annual Meeting
DESCRIPTION:The ASGCT Annual Meeting is the leading global event for professionals in gene and cell therapy\, hosted by the American Society of Gene + Cell Therapy (ASGCT) to showcase cutting-edge research\, new technologies\, and clinical applications\, offering crucial networking for scientists\, industry leaders\, and clinicians to advance treatments for human diseases. It features expert presentations\, novel abstract presentations\, workshops\, and exhibitions from companies in the cell and gene therapy ecosystem.
URL:https://thebiocalendar.com/event/asgct-annual-meeting/
LOCATION:Boston\, MA\, 02210\, United States
CATEGORIES:Academic Research,Networking,Presentation
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260511
DTEND;VALUE=DATE:20260516
DTSTAMP:20260530T202935
CREATED:20251206T101440Z
LAST-MODIFIED:20260116T121409Z
UID:9625-1778457600-1778889599@thebiocalendar.com
SUMMARY:PEGS Boston
DESCRIPTION:The PEGS Boston Summit is where the future of biologics takes shape. For over 20 years\, PEGS is the go-to event for protein and antibody engineering\, drug development\, immunotherapy\, radiotherapy\, and AI/ML-driven biologics research. New in 2026: a dedicated focus on peptides\, spotlighting their therapeutic power\, design innovations\, and expanding role in drug discovery. \nWith 350+ presentations\, breakout sessions\, and interactive training seminars\, PEGS delivers the insights and connections you need to stay ahead. The exhibit hall buzzes with top technology and service providers\, giving you a front-row seat to the tools transforming the industry. \nDon’t just follow the science – be part of it. Join us at the 2026 PEGS Boston Summit and connect with the leaders shaping what’s next in biologics and beyond.
URL:https://thebiocalendar.com/event/pegs-boston-3/
LOCATION:Boston\, MA\, 02210\, United States
CATEGORIES:Featured,Summit
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2025/12/pegs2026-scaled.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260511T080000
DTEND;TZID=America/Los_Angeles:20260514T170000
DTSTAMP:20260530T202935
CREATED:20251206T100827Z
LAST-MODIFIED:20251206T100827Z
UID:9622-1778486400-1778778000@thebiocalendar.com
SUMMARY:AAPS National Biotechnology Conference
DESCRIPTION:The AAPS National Biotechnology Conference (NBC) is a premier annual event by the American Association of Pharmaceutical Scientists (AAPS) for leaders in pharma and biotech to explore cutting-edge science in biologics\, advanced therapies\, and innovative drug development\, focusing on new modalities like CAR-T\, gene therapies\, and AI in drug discovery\, bridging research from lab to patient. It features scientific sessions\, poster presentations\, and networking opportunities\, addressing challenges in formulation\, bioanalysis\, manufacturing\, and translational science for complex drugs
URL:https://thebiocalendar.com/event/aaps-national-biotechnology-conference/
LOCATION:San Diego\, San Diego\, CA\, United States
CATEGORIES:Academic Research,Summit,Symposium
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260511T110000
DTEND;TZID=America/Los_Angeles:20260511T120000
DTSTAMP:20260530T202935
CREATED:20260410T130948Z
LAST-MODIFIED:20260410T130948Z
UID:10185-1778497200-1778500800@thebiocalendar.com
SUMMARY:Design scalable downstream processes with practical purification and analytical strategies
DESCRIPTION:Downstream process development is rapidly evolving as new modalities\, from mAbs to mRNA\, viral vectors\, and other complex molecules\, enter development pipelines. This webinar will share practical strategies and analytical considerations for designing robust\, scalable purification processes across diverse molecule types. \nDrawing on decades of chromatography innovation and the expertise of our global Fast Trak™ process development (PD) teams\, Cytiva speakers will show how we use tools such as our Biacore™ surface plasmon resonance (SPR) system and size-exclusion chromatography with multi-angle light scattering (SEC-MALS) to clarify complex mechanisms\, address unpredictable impurities\, and overcome challenges that traditional approaches cannot resolve. \nYou will also hear how the combination of this experience\, advanced analytics\, and focused knowledge transfer can accelerate development\, reduce risk\, and help customers build lasting internal capability and true process ownership. \nUsing case examples spanning proteins\, antibodies\, nucleic acids\, viruses\, and vesicles\, we will feature common downstream pitfalls and highlight how our integrated chromatography and analytical strengths help avoid them. Whether you are advancing proof of concept or preparing to scale up\, you will leave with a clear view of how Cytiva PD\, SPR\, and chromatography leadership enables efficient\, confident downstream development—even for the most complex modalities. \nKey Learning Objectives: \n    Learn practical\, scalable approaches for developing chromatography‑based purification processes\n    Understand how advanced analytical tools such as SPR (Biacore™ system) and SEC‑MALS reveal complex molecular interactions and impurity mechanisms\n    Explore how combining chromatography expertise\, advanced analytics\, and structured knowledge transfer accelerates development and builds long‑term process capability
URL:https://thebiocalendar.com/event/design-scalable-downstream-processes-with-practical-purification-and-analytical-strategies/
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/04/05-11-26-Cytiva-LinkedIn-1280x720-1.png
END:VEVENT
END:VCALENDAR